Scott W. Martin

Person

Middletown, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted bicyclic compounds useful as T cell activators
- Patent number 11,964,973
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Naphthyridinone compounds useful as T cell activators
- Patent number 11,866,430
- Issue date Jan 9, 2024
- Bristol-Myers Squibb Company
- Louis S. Chupak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as immunomodulators
- Patent number 9,850,225
- Issue date Dec 26, 2017
- Bristol-Myers Squibb Company
- Louis S. Chupak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,143,243
- Issue date Mar 27, 2012
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 8,133,884
- Issue date Mar 13, 2012
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,652,004
- Issue date Jan 26, 2010
- Bristol-Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the treatment of hepatitis C
- Patent number 7,642,251
- Issue date Jan 5, 2010
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
- Patent number 7,521,441
- Issue date Apr 21, 2009
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indolobenzazepine HCV NS5B inhibitors
- Patent number 7,473,688
- Issue date Jan 6, 2009
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HCV NS5B inhibitors
- Patent number 7,456,165
- Issue date Nov 25, 2008
- Bristol-Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,348,425
- Issue date Mar 25, 2008
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Iminothiazolidinones as inhibitors of HCV replication
- Patent number 7,183,302
- Issue date Feb 27, 2007
- Bristol-Myers Squibb Company
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of HCV replication
- Patent number 7,153,848
- Issue date Dec 26, 2006
- Bristol-Myers Squibb Company
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cycloalkyl heterocycles for treating hepatitis C virus
- Patent number 7,112,601
- Issue date Sep 26, 2006
- Bristol-Myers Squibb Company
- Peter W. Glunz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alkylamine derivatives of dihydropyridine NPY antagonists
- Patent number 6,479,482
- Issue date Nov 12, 2002
- Bristol-Myers Squibb Company
- Graham S. Poindexter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphenyl imidazoles as potassium channel modulators
- Patent number 6,271,249
- Issue date Aug 7, 2001
- Bristol-Myers Squibb Company
- Jeffrey L. Romine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphenyl triazoles as potassium channel modulators
- Patent number 6,077,861
- Issue date Jun 20, 2000
- Bristol-Myers Squibb Company
- Jeffrey L. Romine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphenyl oxadiazolones as potassium channel modulators
- Patent number 5,869,509
- Issue date Feb 9, 1999
- Bristol-Myers Squibb Company
- Jeffrey L. Romine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
- Patent number 5,380,854
- Issue date Jan 10, 1995
- Bristol-Myers Squibb Company
- Jeffrey L. Romine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
- Patent number 5,254,576
- Issue date Oct 19, 1993
- Bristol-Myers Squibb Company
- Jeffrey L. Romine
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210277004
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210188845
- Publication date Jun 24, 2021
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Useful as Immunomodulators
- Publication number 20150291549
- Publication date Oct 15, 2015
- Bristol-Myers Squibb Company
- Louis S. Chupak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090280083
- Publication date Nov 12, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090275561
- Publication date Nov 5, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090074715
- Publication date Mar 19, 2009
- Bristol -Myers Squibb Company
- Scott W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the Treatment of Hepatitis C
- Publication number 20090042860
- Publication date Feb 12, 2009
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
- Publication number 20070270406
- Publication date Nov 22, 2007
- Bristol -Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HCV NS5B Inhibitors
- Publication number 20070185083
- Publication date Aug 9, 2007
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indolobenzazepine HCV NS5B inhibitors
- Publication number 20070078122
- Publication date Apr 5, 2007
- Bristol -Myers Squibb Company
- Carl P. Bergstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HCV replication
- Publication number 20060166964
- Publication date Jul 27, 2006
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of HCV replication
- Publication number 20060046983
- Publication date Mar 2, 2006
- Thomas W. Hudyma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Iminothiazolidinones as inhibitors of HCV replication
- Publication number 20050096364
- Publication date May 5, 2005
- Jeffrey Lee Romine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cycloalkyl heterocycles for treating Hepatitis C virus
- Publication number 20050075376
- Publication date Apr 7, 2005
- Peter W. Glunz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination pharmaceutical agents as inhibitors of HCV replication
- Publication number 20050069522
- Publication date Mar 31, 2005
- Richard Colonno
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Alkylamine derivatives of dihydropyridine NPY antagonists
- Publication number 20020019384
- Publication date Feb 14, 2002
- Graham S. Poindexter
- C07 - ORGANIC CHEMISTRY

Scott W. Martin

Person

Patents Grantslast 30 patents

Substituted bicyclic compounds useful as T cell activators

Naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Compounds useful as immunomodulators

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Compounds for the treatment of hepatitis C

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

Indolobenzazepine HCV NS5B inhibitors

HCV NS5B inhibitors

Inhibitors of HCV replication

Iminothiazolidinones as inhibitors of HCV replication

Inhibitors of HCV replication

Cycloalkyl heterocycles for treating hepatitis C virus

Alkylamine derivatives of dihydropyridine NPY antagonists

Diphenyl imidazoles as potassium channel modulators

Diphenyl triazoles as potassium channel modulators

Diphenyl oxadiazolones as potassium channel modulators

Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors

Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors

Patents Applicationslast 30 patents

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

Compounds Useful as Immunomodulators

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Compounds for the Treatment of Hepatitis C

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

HCV NS5B Inhibitors

Indolobenzazepine HCV NS5B inhibitors

Inhibitors of HCV replication

Inhibitors of HCV replication

Iminothiazolidinones as inhibitors of HCV replication

Cycloalkyl heterocycles for treating Hepatitis C virus

Combination pharmaceutical agents as inhibitors of HCV replication

Alkylamine derivatives of dihydropyridine NPY antagonists